GWM
MSOS icon

Geneos Wealth Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Geneos Wealth Management’s Portfolio MSOS Stock Details MSOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Buy
152,346
+25,500
+20% +$120K 0.02% 607
2026
Q1 		$450K Buy
126,846
+36,650
+41% +$150K 0.01% 728
2025
Q4 		$426K Sell
90,196
-26,618
-23% -$119K 0.01% 712
2025
Q3 		$560K Buy
116,814
+3,500
+3% +$13.8K 0.01% 623
2025
Q2 		$273K Sell
113,314
-5,950
-5% -$14.6K 0.01% 891
2025
Q1 		$311K Sell
119,264
-6,640
-5% -$21.4K 0.01% 764
2024
Q4 		$480K Sell
125,904
-4,950
-4% -$26.7K 0.02% 606
2024
Q3 		$938K Sell
130,854
-7,450
-5% -$52.9K 0.04% 424
2024
Q2 		$1.01M Sell
138,304
-3,200
-2% -$27.9K 0.05% 359
2024
Q1 		$1.42M Buy
141,504
+33,260
+31% +$291K 0.06% 299
2023
Q4 		$759K Sell
108,244
-1,625
-1% -$10.8K 0.04% 380
2023
Q3 		$872K Sell
109,869
-1,700
-2% -$10.7K 0.04% 339
2023
Q2 		$618K Buy
111,569
+100
+0.1% +$548 0.03% 423
2023
Q1 		$634K Sell
111,469
-1,330
-1% -$8.8K 0.04% 395
2022
Q4 		$788K Sell
112,799
-1,300
-1% -$13.4K 0.05% 320
2022
Q3 		$1.02M Sell
114,099
-4,546
-4% -$52.5K 0.07% 251
2022
Q2 		$1.23M Buy
118,645
+18,780
+19% +$279K 0.06% 278
2022
Q1 		$2.08M Buy
99,865
+20,295
+26% +$443K 0.09% 216
2021
Q4 		$2.04M Buy
79,570
+13,826
+21% +$382K 0.08% 250
2021
Q3 		$2.06M Buy
65,744
+22,575
+52% +$782K 0.08% 242
2021
Q2 		$1.75M Buy
43,169
+13,309
+45% +$541K 0.07% 259
2021
Q1 		$1.27M Buy
29,860
+6,431
+27% +$297K 0.04% 369
2020
Q4 		$921K Buy
+23,429
New +$698K 0.04% 369

Other funds holding MSOS

AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Geneos Wealth Management's MSOS Position: Q2 2026 in Review

Geneos Wealth Management increased its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 20% in Q2 2026, buying an estimated $120K and bringing the position to 152,346 shares worth $774K. The position accounts for 0.02% of the portfolio, ranked #607.

Geneos Wealth Management first reported a position in MSOS in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.08M in Q1 2022. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Geneos Wealth Management held 152,346 shares of AdvisorShares Pure US Cannabis ETF worth $774K as of Q2 2026.
  • Geneos Wealth Management bought 25,500 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $120K.
  • AdvisorShares Pure US Cannabis ETF made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #607 holding.
  • Geneos Wealth Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2020 and has held it in 23 quarters since.
  • Geneos Wealth Management's AdvisorShares Pure US Cannabis ETF position peaked at $2.08M in Q1 2022.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.